SRTD Biotech
Germany
◆ Total Raised
$35.1M
◆ Stage
seed
◆ Location
Germany
◆ About SRTD Biotech
Germany-based biotech company developing cell-selective RNA therapies using selectively expressed RNA (seRNA) technology for cancer, autoimmune diseases and fibrosis.
◆ Sectors
◆ Backing funds on Raise
◆ Funding rounds
9 Nov 2026
Led by Mérieux Equity Partners, Boehringer Ingelheim Venture Fund, NRW.BANK
With NRW.BANK, Lilly Ventures, High-Tech Gründerfonds (HTGF), Anobis, HTGF, Anobis Asset
◆ Explore the market
◆ FAQ
What does SRTD Biotech do?
Germany-based biotech company developing cell-selective RNA therapies using selectively expressed RNA (seRNA) technology for cancer, autoimmune diseases and fibrosis.
Where is SRTD Biotech based?
SRTD Biotech is based in Germany.
How much has SRTD Biotech raised?
SRTD Biotech has raised $35.1M in tracked funding and is currently at the seed stage.
Who has invested in SRTD Biotech?
Investors in SRTD Biotech include Boehringer Ingelheim Venture Fund.